Vanguard Asset Management »

Arcus Biosciences Incorporated shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2M 56k 21.60

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Wellington Management Company
Suvretta Capital Management
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Woodline Partners
Marshall Wace
Siren
Geode Capital Management
Fisher Investments
Caption Management
Samlyn Capital

View all funds holding Arcus Biosciences Incorporated